[1] |
Abstracts of the 4th Annual International Conference of the Saudi Society of Nephrology[J]. Saudi J Kidney Dis Transpl,2009,20(5):891-939.
|
[2] |
KALANTAR-ZADEH K,ABBOTT K C,KRONENBERG F,et al.Epidemiology of dialysis patients and heart failure patients[J]. Semin Nephrol,2006,26(2):118-133.
|
[3] |
COLLINS A J,KASISKE B,HERZOG C,et al. Excerpts from the United States Renal Data System2003 Annual Data Report:atlas of end-stage renal disease in the United States[J]. Am J Kidney Dis,2003,45(1 Suppl 1):A5-A7,S1-S230.
|
[4] |
HOU F,JIANG J,CHEN J,et al.China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis[J]. BMC Nephrol,2012,13:94.
|
[5] |
WATTANAKIT K,CUSHMAN M,STEHMAN-BREEN C,et al.Chronic kidney disease increases risk for venous thromboembolism[J]. J Am Soc Nephrol,2008,19(1):135-140.
|
[6] |
MOODY W E,EDWARDS N C,MADHANI M,et al.Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association?[J]. Atherosclerosis,2012,223(1):86-94.
|
[7] |
SARNAK M J,LEVEY A S,SCHOOLWERTH A C,et al.Kideny disease as a risk factor for development of cardiovascular disease:a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease,High Blood Pressure Research,Clinical Cardiology,and Epidemiology and Prevention[J]. Circulation,2003,108(17):2154-2169.
|
[8] |
贾凤玉,孟建中. 慢性肾脏病(透析)患者的心血管疾病诊疗指南解读[J]. 中国血液净化,2011,10(10):570-575.
|
[9] |
ANDERSON K M,CASTELLI W P,LEVY D.Cholesterol and mortality. 30 years of follow-up from the Framingham study[J]. JAMA,1987,257(16):2176-2180.
|
[10] |
沈晓洁,吴灏,余日臻,等. 血液透析患者营养状况与逆流行病学现象的探讨[J]. 第二军医大学学报,2015,36(1):14-18.
|
[11] |
李芹. 维持性血液透析患者死亡原因及危险因素分析[D]. 泸州:泸州医学院,2014.
|
[12] |
段绍霞,蔡宏,张伟明,等. 维持性血液透析患者营养不良-炎症复合体综合征与预后的关系研究[J]. 上海交通大学学报(医学版),2015,35(12):1851-1857.
|
[13] |
LIU Y,CORESH J,EUSTACE J A,et al.Association between cholesterol level and mortality in dialysis patient:role of inflammation and malnutrition[J]. JAMA,2004,291(4):451-459.
|
[14] |
COLLADO S,COLL E,DEULOFEU R,et al.Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors[J]. Nefrologia,2010,30(3):342-348.
|
[15] |
魏娜,刘秀娟,尹秀英,等. 维持性血液透析心血管事件与脂质代谢紊乱的关系[J]. 南昌大学学报(医学版),2015,60(1):59-61.
|
[16] |
SILBERNAGEL G,GENSER B,DRECHSLER C,et al.HDL cholesterol,apolipoproteins,and cardiovascular risk in hemodialysis patients[J]. J Am Soc Nephol,2014,26(2):484-492.
|
[17] |
ELMACHTANI IDRISSI S,DAMI A,BOUHSAIN S,et al.Lipid profile of patients on chronic hemodialysis(Morocco)[J]. Sante,2011,21(1):27-31.
|
[18] |
王宁宁. 尿毒症患者血管钙化的组织学研究及相关分子机制的探讨[D]. 南京:南京医科大学,2006.
|
[19] |
吕玉凤,刘必成. 透析患者心血管疾病危险因素的逆流行病学现象[J]. 中华肾脏病杂志,2006,22(3):183-186.
|
[20] |
BARADARI A G,EMAMI ZEYDI A,ESPAHBODI F,et al.Evaluation of serum C-reactive protein level and its related factors in hemodialysis patients in Sari,Iran[J]. Pak J Biol Sci,2011,14(10):595-599.
|
[21] |
YE X,WEI L,PEI X,et al.Application of creatinine- and/or cystatin C-based glomerular filtration rate estimation equations in elderly Chinese[J]. Clin Interv Aging,2014,9:1539-1549.
|
[22] |
莫惠芳,吴炯,宋斌斌,等. NT-proBNP在心血管疾病高危人群中长期预后的作用[J]. 检验医学,2014,29(10):1013-1018.
|
[23] |
朱笑频,王成刚. NT-proBNP和cTnI联合检测在急诊心力衰竭患者诊治中的应用[J]. 检验医学,2013,28(1):30-32.
|
[24] |
CODOGNOTTO M,PICCOLI A,ZANINOTTO M,et al.Effect of a dialysis session on the prognostic values of NT-proBNP,troponins,endothelial damage and inflammation biomarkers[J]. J Nephrol,2010,23(4):465-471.
|